INTRODUCTION
============

Human astroviruses (HAstVs) are enteric pathogens that cause acute gastroenteritis in young children and immunocompromised/elderly people. The prevalence of classic HAstV infection ranges from 2% to 9% in children with diarrhea, although incidences of 61% have been reported \[[@B1][@B2][@B3][@B4][@B5][@B6]\]. They are non-enveloped, single-stranded, positive-sense RNA viruses of approximately 6.8 kb in length that contain three overlapping open reading frames (ORFs): *ORF1a*, *ORF1b*, and *ORF2*. *ORF1a* and *OFR1b* encode the non-structural viral proteins, including RNA-dependent RNA polymerase, and *ORF2* encodes the capsid protein precursor that is cleaved into capsid proteins VP34, VP27, and VP25 \[[@B1]\]. Sequence variation among astroviruses is the greatest in the *ORF2* region, which encodes a highly conserved N-terminal domain (aa 1--424), a hypervariable domain (HVR) (aa 425--688), and a C-terminal domain \[[@B1]\].

Classic HAstVs (*Mamastrovirus* 1) have been classified into eight genotypes on the basis of capsid antigenicity. HAstV Type 1 is the most prevalent genotype, whereas Types 2--8 are less prevalent \[[@B1][@B2][@B3][@B5]\]. HAstV Type 2 was the most prevalent genotype in Sao Paulo, Brazil, in 1994--1996, and in Mexico, in 1988--1991 \[[@B7][@B8]\], and HAstV Type 5 was the most prevalent genotype in Linyi, China, in 2013 \[[@B9]\]. Therefore, the genotypic distribution of HAstVs may vary geographically and temporally \[[@B1]\]. In Korea, several studies have examined the positive rate and genotype of HAstVs, but they have been conducted either several years ago or for very short durations \[[@B10][@B11][@B12][@B13][@B14]\]. We investigated the positive rate of HAstVs and the distribution of HastV genotypes in Hwaseong, a city with high population density in Korea, in 2013--2017 and examined the sequence variations of HAstVs.

METHODS
=======

Samples
-------

Between November 2013 and December 2017, 3,519 stool samples from patients with acute gastroenteritis were tested for diarrhea-causing viruses in the laboratory of Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea. After the test, residual positive stool samples were routinely collected and stored at −70℃ until use. This study was retrospectively performed on stored HAstV-positive stool samples. The study protocol was approved by the Institutional Review Board (IRB) of Hallym University Dongtan Sacred Heart Hospital (IRB No. 2014-069, NON-2018-003), with waivers of informed consent. Data regarding the patients\' ages and symptoms were collected by reviewing patients\' medical records.

PCR
---

Stool samples were diluted to a 10% suspension in phosphate-buffered saline, and viral RNA was extracted using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) and the QIAcube platform (Qiagen). HAstV was detected using Seeplex Diarrhea-V ACE Detection assays (Seegene, Seoul, Korea), which employ a multiplex PCR technique for detecting rotavirus, norovirus, adenovirus, and HAstV simultaneously, and a PTC-200 Thermal Cycler (Bio-Rad, Hercules, CA, USA). All procedures were performed according to the manufacturers\' instructions. After PCR, residual positive samples were collected and stored at −70℃ for further study.

Genotyping
----------

Genotyping was performed by reverse-transcription (RT) PCR and sequencing in January 2018. HAstV PCR-positive stored stool samples were thawed, and viral RNA was extracted again from these samples. cDNA was generated from RNA using the Invitrogen SuperScript III First Strand Synthesis System (Thermo Fisher Scientific, Waltham, MA, USA) and used for PCR with DNA AmpliTaq Gold Taq (Applied Biosystems, GmbH, Weiterstadt, Germany). We used a gene-specific primer set, PreCAP1 (5′-GGACTGCAAAGCAGCTTCGTG-3′) and 82b (5′-GTGAGCCACCAGCCATCCCT-3′), which targets the *ORF2* gene and generates a 719-bp PCR product \[[@B15]\]. For samples that did not yield a PCR product using these primers, multiplex PCR was conducted using a different primer set that could amplify all classic serotypes of HAstVs \[[@B16]\]. A positive control (RNA extracted from the sample of an HAstV-positive patient) and a negative control (RNase-free water) were co-amplified to assess false-negative and false-positive results, respectively. PCR products were visualized after agarose gel electrophoresis, purified using the QIAquick PCR Purification Kit (Qiagen), and sequenced using ABI BigDye Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems Inc., Foster City, CA, USA) on the 3500XL Genetic Analyzer (Thermo Fisher Scientific). HAstV genotypes of the obtained sequences were determined by BLAST searches against the GenBank database.

Phylogenetic analysis
---------------------

Phylogenetic analysis was conducted to evaluate genetic relationships between the HAstVs obtained and the closest strains in GenBank. The accession numbers of the closest strains were KM981712.1, MG932591.1, JQ898572.1, KP453847.2, KM981734.1, MG932580.1, KF420152.1, MG932569.1, KP862744.1, and NC_001943.1. The HAstV sequences were aligned using MEGA version 7 \[[@B17]\]. Phylogenetic trees were constructed using the maximum-likelihood method and Tamura-Nei substitution models with 1,000 bootstrap replications, using MEGA version 7.

Nucleotide sequence accession numbers
-------------------------------------

The GenBank accession numbers for the nucleotide sequences of the genomes of strains D-1415, D-1312, D-269, and D-123 in this study are MK430063, MK472054, MK472055, and MK472056.

RESULTS
=======

Positive rates and patient characteristics
------------------------------------------

HAstV positive rates according to patient age are shown in [Table 1](#T1){ref-type="table"}. The average positive rate between 2013 and 2017 was 1.9%, and the ages of HAstV-positive patients ranged from 55 days to 81 years (median, 3 years, and average, 15.7 years). Prevalence was higher in children under five years; however, 26 out of 67 patients (38.8%) were over five years. [Table 2](#T2){ref-type="table"} shows the major symptoms of HAstV infection based on the patients\' medical records. All patients showed at least one of the symptoms: diarrhea, nausea or vomiting, abdominal or epigastric pain, and fever. Monthly positive rates are shown in [Fig. 1](#F1){ref-type="fig"}. The highest positive rates in each year were observed during November in 2013 (11.1%, 3/27), June in 2014 (9.4%, 6/64), April in 2015 (5.6%, 6/107), March in 2016 (8.6%, 3/35), and July in 2017 (4.9%, 7/143). In 24 of the total 50 months considered, HAstV was not detected.

Genotypes
---------

Of 67 HAstV-positive samples, 51 were successfully genotyped ([Table 3](#T3){ref-type="table"}). Eight samples were discarded after PCR by mistake, and eight samples yielded no PCR product with the genotyping primer sets used in this study. HAstV Type 1 was the most prevalent (82.4%), and Types 4, 5, and 8 were also detected. Types 5 and 8 were detected only in 2014, whereas Type 4 was detected in 2015, 2016, and 2017 ([Table 3](#T3){ref-type="table"}).

Phylogenetic analysis
---------------------

Phylogenetic analysis is shown in [Fig. 2](#F2){ref-type="fig"}. There were three distinct clades among HAstV Type 1 according to three time periods (2013--2014, 2014--2016, and 2017). The five strains detected in 2017 (D-1389, D-1397, D-1413, D-1415, and D-1421) were phylogenetically closest to an HAstV strain detected in Russia in 2017 (MG932591.1). The four strains detected in 2013 and 2014 (D-34, D-36, D-343, and D-423) were phylogenetically closest to a strain detected in Thailand in 2011 (JQ898572.1), and most strains detected during 2014--2016 were phylogenetically closest to a strain detected in China in 2013 (KM981712.1). The three strains of HAstV Type 4 (D-856, D-1153, and D-1403) were phylogenetically closest to a strain detected in Russia in 2017 (MG932580.1) and one detected in China in 2013 (KM981734.1). The three strains of HAstV Type 5 (D-52, D-233, and D-322) were closest to a strain detected in Bangladesh in 2012 (KF420152.1) and one detected in Russia in 2012 (MG932569.1). The three strains of HAstV Type 8 (D-123, D-230, and D-269) were the closest to a strain detected in Korea in 2014 (KP862744.1).

DISCUSSION
==========

The overall HAstV positive rate in this study was 1.9%. The positive rate of HAstV differs across regions \[[@B1]\] from 0.21% in Chongquing, China \[[@B18]\] to 61% in Mayan infants \[[@B19]\], while the average incidence worldwide is 11% \[[@B1]\]. The positive rate of HAstV can differ with respect to time and has tended to decrease in the last decade \[[@B1]\]. In Korea, the HAstV positive rate was less than 2% \[[@B10][@B11][@B12][@B13]\], and only one study reported a positive rate up to 4% in Cheonan \[[@B14]\]. The present study confirmed that the positive rate of HAstV in Korea in recent years is still lower than the average global positive rate of 11% \[[@B1]\]. This may be due to the current socio-economic and sanitary status of Korea \[[@B20]\].

HAstVs are considered to cause infections mainly in children younger than five years \[[@B1]\]. However, in this study, 38.8% of HAstV-positive patients were older than five years, which suggests that HAstV infection may also occur in adolescents and adults. The higher percentage of patients over five years in this study could be attributed to the fact that we collected stool samples from patients of all ages with diarrhea symptoms.

Analysis of the monthly positive rate by year did not show distinct seasonal variations in HAstV infection. Cumulative positive rates revealed a relatively high HAstV incidence from March to July and a relatively low incidence from August to October; however, definitive conclusions cannot be drawn because of the small number of positive samples.

Although HAstV Type 1 was the most prevalent (82.4%), we also detected Types 4, 5, and 8. With a few exceptions, HAstV Type 1 is the most common worldwide \[[@B1]\]. Type 4 was the second most prevalent genotype in Argentina (25%, 1995--1998 \[[@B21]\]), Spain (26%, 1997--2000 \[[@B22]\]), and Australia (15%, 1995 \[[@B23]\]). Type 8 has been detected at a relatively higher frequency in India (16%, 2004--2008 \[[@B24]\]) and Spain (11%, 1997--2000 \[[@B22]\]) than in previous research \[[@B1]\]. Type 5 has been detected at high frequency in Egypt (15.7%, 1995) \[[@B1][@B25]\]. We confirmed that Types 5 and 8 strains were isolated only in 2014 and were not small outbreaks or family transmissions, by reviewing patients\' medical records. HAstV Types 4, 5, and 8 have been reported in Korea \[[@B10][@B13]\]. Phylogenic analysis showed that the sequences of HAstV Type 1 isolated in this study between November 2013 and August 2017 could be grouped into three clades related to three periods, which may suggest genetic evolution of HAstVs over this period in Korea. This is the first study to analyze a phylogeny of HAstVs according to isolation time in Korea.

One limitation of this study was that only samples that tested positive with the commercially available Seeplex PCR assay were genotyped; thus, types that did not test positive with this assay were probably not detected. The company claims that this PCR assay can detect HAstV Types 1--8, but this assay may not detect HAstVs whose genomes have variations at primer-binding sites. If all the 3,519 samples in this study had been genotyped without the PCR screening procedure, the positive rate of HAstV might have been higher and a greater variety of genotypes may have been detected, because HAstV detection in stool samples might differ according to the detection method and primer pair used.

In conclusion, our results provide recent data on positive rates, genotypes, and sequence variations of HAstVs in Korea between 2013 and 2017. The finding of three distinct clades of HAstV Type 1 according to collection time suggests the genetic evolution of HAstVs. These findings can enhance our knowledge on HAstV infection and viral evolution.
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![Phylogenetic analysis of HAstVs in this study and reference strains in GenBank. Phylogenetic trees were constructed using the maximum-likelihood method with 1,000 bootstrap replications, using MEGA version 7. The percentage of trees, in which the associated taxa clustered together is shown next to the branches. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. Black circles indicate the HAstV isolates from this study, white squares indicate the reference species from GenBank, and strains are described in terms of accession number, type of HAstV, country of collection, and year of collection.\
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###### Age distribution of HAstV-positive patients

![](alm-39-367-i001)

  Age (year)   Patients tested (N)   HAstV-positive patients, N (%)
  ------------ --------------------- --------------------------------
  \<1          0367                  15 (4.1)
  1--5         603                   26 (4.3)
  6--10        205                   1 (0.5)
  11--20       259                   4 (1.5)
  21--30       376                   6 (1.6)
  31--40       411                   7 (1.7)
  41--50       292                   0 (0.0)
  51--60       291                   3 (1.0)
  61--70       275                   3 (1.1)
  \> 71        440                   2 (0.5)
  Total        3,519                 67 (1.9)

Abbreviation: HAstV, human astrovirus.

###### Symptoms of HAstV-positive patients (N=67)
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  Symptoms                                                                Patients, N (%)
  ----------------------------------------------------------------------- -----------------
  Diarrhea                                                                53 (79.1)
  Nausea or vomiting                                                      29 (43.3)
  Abdominal or epigastric pain                                            19 (28.3)
  Fever                                                                   37 (55.2)
  Absence of diarrhea, nausea, vomiting, or abdominal pain (only fever)   3 (4.5)

Abbreviation: HAstV, human astrovirus.

###### Yearly positive rates of HAstV as determined by PCR and genotypes of HAstVs
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  Year     Samples tested, N   Positive samples, N (%)   Samples genotyped, N   Genotype(s) detected   Isolates per genotype, N (%)
  -------- ------------------- ------------------------- ---------------------- ---------------------- ------------------------------
  2013     74                  6 (8.1)                   3                      Type 1                 3
  2014     889                 24 (2.7)                  20                     Type 1                 14
  Type 5   3                                                                                           
  Type 8   3                                                                                           
  2015     876                 18 (2.1)                  17                     Type 1                 16
  Type 4   1                                                                                           
  2016     581                 5 (0.9)                   3                      Type 1                 2
  Type 4   1                                                                                           
  2017     1,099               14 (1.3)                  8                      Type 1                 7
  Type 4   1                                                                                           
  Total    3,519               67 (1.9)                  51                     Type 1                 42 (82.4)
  Type 4   3 (5.9)                                                                                     
  Type 5   3 (5.9)                                                                                     
  Type 8   3 (5.9)                                                                                     

Abbreviation: HAstV, human astrovirus.
